Change for Good
by understanding the psychology behind health behaviour

Change for Good
by empowering people to play an active role in their own health

Change for Good
by improving outcomes, including adherence and wider health behaviours

We see the person beyond the patient

Adopting healthy behaviours can be difficult without the right skills, confidence and motivation.

Our evidence-based approach to designing personalised behaviour change solutions targets each individual’s needs, health beliefs and behaviour challenges.

Based on their unique profile, we engage them with the right support at the right time, empowering people to overcome the practical and emotional challenges of living with a long-term health condition.

A fully collaborative approach

To create Change for Good, we collaborate with healthcare and life sciences organisations and with people living with long-term health conditions.

For over 25 years, we have co-designed engaging and evidence-based behaviour change solutions that blend health psychology expertise and proprietary data-driven personalisation technologies. 

Together, we empower people to overcome key challenges at each stage of the health journey. We deliver valued services and support that complements their medical care experience and improves health outcomes. 

We're there at every stage on the health journey

At each stage, people living with a long-term condition face challenges that they can overcome more easily with personalised support and services designed to motivate positive treatment and lifestyle behaviours.

Pre-diagnosis
Active

Activate

Bespoke and configurable solutions to help people recognise symptoms or signs that need healthcare professional input, and that motivate the adoption of preventive health behaviours.

Diagnosis
Accept

Accept

Evidence-based tools and specialised training to guide effective doctor-patient dialogue and support shared healthcare decision-making in response to a new diagnosis, disease progression, or when considering new treatment options.

Treatment initiation
Access

Access

Tailored services and added support for treatment reimbursement processes, delivery of prescribed medications, and related training needs to provide a seamless experience for patients and healthcare professionals.

Illness self-management
Empower

Empower

Highly personalised, multichannel support programmes designed to build skills, confidence and motivation to manage the practical and emotional impact of living with long-term conditions.

For more details and results from Atlantis Health's behaviour change solutions, contact us for case studies relevant to your needs. You can also review our peer-reviewed publications

We engage people to deliver better outcomes

Through both in-house and global partner capabilities, we provide behaviour change solutions around the world through a wide array of engagement channels and platforms. Our capabilities range from at-home and telephone-based support from skilled health coaches to individually tailored and timely digital experiences. 

We constantly assess and evolve our personalisation algorithms and proprietary data-driven technologies to deliver highly relevant, engaging and scalable solutions. As a result, satisfaction and retention rates among people who experience our solutions are consistently high.

News and publications

Our latest health psychology-based insights as well as published results of solutions we've designed to address specific health behaviour change challenges.

Atlantis Health Engages University of Miami’s Michael H. Antoni, PhD

Atlantis Health, a pioneer and global leader in health psychology-based pat…

The Shock of the New

A chronic illness diagnosis can have significant psychological impacts on t…

Evidence for Change: Health literacy

This first issue of our Evidence for Change series provides a brief, eviden…

We work with the world’s leading healthcare
companies at the global and local level

We've partnered with like-minded clients to create personalised behaviour change solutions that empower people with long-term conditions in over 30 countries.

Abbvie
Bayer
GSK
Janssen
Lilly
Novartis
Nzblood
Roche
Sanofi
Takeda
UCB
Merck